background image

Paid Clinical Trials Jackson

Discover 228 paid clinical trials in Jackson, Mississippi. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Trial Comparing Unrelated Donor BMT with IST for Pediatric and Young Adult Patients with Severe Aplastic Anemia (TransIT, BMT CTN 2202)

Recruiting
PHASE3

Sponsor:

Boston Children's Hospital

Location:

Jackson MS, New Orleans LA, Memphis TN, Little Rock ARshow 43 more

Code:

NCT05600426

Conditions

Severe Aplastic Anemia

Eligibility Criteria

Sex: All

Age: 0 - 25

Healthy Volunteers: Not accepted

Interventions

cyclosporine

Matched Unrelated Donor Hematopoetic Stem Cell Transplant

horse anti-thymocyte globulin (ATG)

rabbit anti-thymocyte globulin (ATG)

Methotrexate

Study to Assess the Safety and Efficacy of OCU410ST for Stargardt Disease

Recruiting
PHASE1
PHASE2

Sponsor:

Ocugen

Location:

Jackson MS, Bellaire TX, Dallas TX, Durham NCshow 2 more

Code:

NCT05956626

Conditions

Stargardt Disease

Eligibility Criteria

Sex: All

Age: 6 - 65

Healthy Volunteers: Not accepted

Interventions

OCU410ST

National Collaborative to Improve Care of Children With Complex Congenital Heart Disease

Recruiting

Sponsor:

Children's Hospital Medical Center, Cincinnati

Location:

Jackson MS, Jefferson LA, New Orleans LA, Memphis TNshow 53 more

Code:

NCT02852031

Conditions

Hypoplastic Left Heart Syndrome (HLHS)

Eligibility Criteria

Sex: All

Age: 0 - 15

Healthy Volunteers: Not accepted

Interventions

Collaborative Learning Network

Cerebral Palsy Hip Outcomes Project - International Multi-centre Study

Recruiting

Sponsor:

Holland Bloorview Kids Rehabilitation Hospital

Location:

Jackson MS, Cincinnati OH, Saint Paul MN, Aurora COshow 7 more

Code:

NCT01987882

Conditions

Cerebral Palsy

Eligibility Criteria

Sex: All

Age: 2 - 18

Healthy Volunteers: Not accepted

Selinexor in Maintenance Therapy After Systemic Therapy for Participants With p53 Wild-Type, Advanced or Recurrent Endometrial Carcinoma

Recruiting
PHASE3

Sponsor:

Karyopharm Therapeutics Inc

Location:

Jackson MS, Baton Rouge LA, New Orleans LA, Germantown TNshow 71 more

Code:

NCT05611931

Conditions

Endometrial Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Selinexor

Matching Placebo for selinexor

A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH

Recruiting
PHASE3

Sponsor:

89bio, Inc.

Location:

Flowood MS, Lafayette LA, Cordova TN, Little Rock ARshow 83 more

Code:

NCT06419374

Conditions

Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Pegozafermin

Placebo

Cryospray Therapy Versus Standard of Care for Benign Airway Stenosis (CryoStasis)

Recruiting

Sponsor:

Vanderbilt University Medical Center

Location:

Jackson MS, Nashville TN, Richmond VA

Code:

NCT04996173

Conditions

Pulmonary Disease

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Spray cryotherapy

Ballon Dilation

Radial Incision

A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

Recruiting
PHASE3

Sponsor:

Eli Lilly and Company

Location:

Ridgeland MS, New Orleans LA, Little Rock AR, Birmingham ALshow 73 more

Code:

NCT04396574

Conditions

Migraine

Eligibility Criteria

Sex: All

Age: 6 - 17

Healthy Volunteers: Not accepted

Interventions

Lasmiditan

A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to Treatment

Recruiting
PHASE3

Sponsor:

Janssen Research & Development, LLC

Location:

Jackson MS, New Orleans LA, Memphis TN, Little Rock ARshow 29 more

Code:

NCT05455320

Conditions

Relapsed or Refractory Multiple Myeloma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Talquetamab

Daratumumab

Pomalidomide

Dexamethasone

A Study of Baricitinib (LY3009104) in Children With COVID-19

Recruiting
PHASE3

Sponsor:

Eli Lilly and Company

Location:

Jackson MS, Galveston TX, Orlando FL, Charlottesville VAshow 3 more

Code:

NCT05074420

Conditions

Covid19

Corona Virus Infection

Eligibility Criteria

Sex: All

Age: 2 - 18

Healthy Volunteers: Not accepted

Interventions

Baricitinib